0 items USD 0.00Search
Your search for "current partnering global parkinsons disease partnering 2010 2016" gave back 48503 results.
The global Neurodegenerative Disease market size was valued at US$ 6850.9 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Neurodegenerative diseases largely refer to incremental damage to nerve cells in different parts of the body. These ailments, including Alzheimer’s...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Neurodegenerative diseases largely refer to incremental damage to nerve cells in different parts of the body. These ailments, including Alzheimer’s...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Anti-Parkinson Drugs are drugs used to treat Parkinson's disease. The “Anti-Parkinson Drugs Industry Forecast” looks at past sales and reviews...
Catalog:
LPI
March 2023
Price: USD 3,660.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Neurodegenerative Diseases Therapeutics market will...
Catalog:
Arsta
August 2022
Price: USD 3,360.00
Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Apomorphine Hydrochloride market size was valued at US$ 271.7 million in 2023. With growing demand in downstream market, the Apomorphine...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The Transcranial Magnetic Stimulators industry is at the forefront of revolutionizing brain stimulation techniques for various neurological and...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Neurodegenerative diseases largely refer to incremental damage to nerve cells in different parts of the body. These ailments, including Alzheimer’s...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Neurodegenerative diseases largely refer to incremental damage to nerve cells in different parts of the body. These ailments, including Alzheimer’s...
Catalog:
GIR
February 2023
Price: USD 3,480.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Neurodegenerative Diseases Therapeutics market will...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
Cardiac Rehabilitation is the process by which patients with cardiac disease, in partnership with a multidisciplinary team of health professionals...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Rivastigmine market size was valued at US$ million in 2023. With growing demand in downstream market, the Rivastigmine is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Central nervous system (CNS) disease is a broad category of conditions in which the brain does not function as it should, limiting health and the...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
